Krishan Jethwa

Krishan Jethwa discussing the LAPIS trial on locally advanced PDAC

Krishan Jethwa, GI Radiation Oncologist at Mayo Clinic, shared a post on X:

“LAPIS Trial.

Locally advanced PDAC.

Randomized

SoC Systemic therapy (FOLFIRINOX or GnP)

+/-

Pamrevlumab (PAM)

Unfortunately, no improvement in OS, EFS or objective response with addition of PAM.”

Krishan Jethwa discussing the LAPIS trial on locally advanced PDAC

Read further.

More posts featuring Krishan Jethwa.

cancer Krishan Jethwa LAPIS OncoDaily Oncology pancreatic ductal adenocarcinoma PDAC